Biomarker– tag –
-
POCT Innovations Accelerate at MEDICA 2026: Biosensors, Imaging AI, and Lab-on-a-Chip Drive Precision Medicine
MEDICA Germany Overview MEDICA 2026 highlights significant advancements in Point-of-Care Testing (POCT), accelerating on-site diagnostics for rapid clinical decision-making. Progress in biosensors, imaging AI, biomarkers, and lab-on-a-ch... -
Multimodal Nanomaterials for Prostate Cancer Theranostics Advance, Integrating Precision Diagnosis and Therapy with PSMA-Targeted Platforms
International Journal of Nanomedicine (IJN) International Overview Research into multimodal nanomaterials for prostate cancer (PCa) theranostics is progressing, offering versatile platforms that integrate molecular imaging, biomarker det... -
Kymera Therapeutics’ Oral STAT6 Degrader KT-621 Shows Positive Phase 1b Atopic Dermatitis Data, Potential Injectable Alternative
TradingView Global Overview Kymera Therapeutics' lead candidate, KT-621 (an oral STAT6 degrader leveraging targeted protein degradation), demonstrated positive Phase 1b data in atopic dermatitis. Presented at the American Academy of Derm... -
Bambusa Therapeutics’ Bispecific Antibody BBT001 Achieves Rapid, Durable Itch Relief and AD Improvement in Phase 1 Atopic Dermatitis Trial
Dermatology Times USA Overview Preliminary Phase 1 clinical data for Bambusa Therapeutics' bispecific antibody BBT001 shows rapid and sustained improvement in disease severity and pruritus in moderate-to-severe atopic dermatitis (AD) pat... -
Cizzle Biotechnology Launches CIZ1B Blood Test for Early Lung Cancer Detection in US Market
The York Press UK Overview UK-based Cizzle Biotechnology Holdings has commenced the commercial rollout of its CIZ1B biomarker blood test for early lung cancer detection in the United States. The initial launch in Dallas-Fort Worth and Sa... -
Freenome Secures FDA Approval for Blood-Based Colorectal Cancer Test, Advancing Non-Invasive Diagnostics
MedTech Dive USA Overview Freenome has received FDA approval for its blood-based test for colorectal cancer, marking a significant regulatory milestone in non-invasive cancer diagnostics. This development is a major advance in the field ... -
CoolLED Spotlights Advanced Multi-Color Imaging Biosensors Enabling Single-Molecule Detection with High Throughput and Sensitivity
CoolLED UK Overview CoolLED highlighted an article discussing a novel biosensor concept that achieves single-molecule imaging with high throughput and sensitivity using a multi-color imaging setup. This advanced biosensor technology sign... -
UT Dallas Researchers Develop Sweat-Based Sensor Aimed at Improving Sleep Quality
UT Dallas News Center USA Overview A bioengineer at UT Dallas is advancing research into a sweat-based sensor designed to help improve sleep quality. This work, related to grants for rare cancer research, highlights the expanding potenti... -
bioRxiv Preprint: SMART-NeuroDx Unveils Reagent-Free, Machine-Learning Biosensor Platform for Point-of-Care Dementia Screening
bioRxiv International Overview A preprint on bioRxiv introduces SMART-NeuroDx, a reagent-free, multianalyte biosensor platform featuring a machine-learning readout for point-of-care dementia screening. The platform utilizes a four-channe... -
Microfluidic Platform Enables Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes, ACS Analytical Chemistry Reports
Analytical Chemistry - ACS Publications USA Overview Research published in ACS Analytical Chemistry describes the development of a microfluidic chip for multiplexed detection of breast cancer-specific miRNA and protein biomarkers on exos...
